Filing Details
- Accession Number:
- 0001437749-23-032461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-17 16:01:39
- Reporting Period:
- 2023-11-15
- Accepted Time:
- 2023-11-17 16:01:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488039 | Atossa Therapeutics Inc. | ATOS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251779 | L Gregory Weaver | C/O Atossa Therapeutics, Inc., 107 Spring Street Seattle WA 98104 | Former Evp, Cfo, & Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-15 | 50,000 | $0.65 | 55 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
